Aesthetic Operating Income vs Net Income From Continuing Ops Analysis

AIH Stock

USD 0.43 0.02 4.44%

Aesthetic Medical financial indicator trend analysis is way more than just evaluating Aesthetic Medical Intl prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aesthetic Medical Intl is a good investment. Please check the relationship between Aesthetic Medical Operating Income and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aesthetic Medical Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Operating Income vs Net Income From Continuing Ops

Operating Income vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aesthetic Medical Intl Operating Income account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Aesthetic Medical's Operating Income and Net Income From Continuing Ops is 0.92. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Aesthetic Medical Intl, assuming nothing else is changed. The correlation between historical values of Aesthetic Medical's Operating Income and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Aesthetic Medical Intl are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Operating Income i.e., Aesthetic Medical's Operating Income and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.92

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Aesthetic Medical Intl operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Aesthetic Medical Intl is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Net Income From Continuing Ops

Most indicators from Aesthetic Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aesthetic Medical Intl current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aesthetic Medical Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

As of now, Aesthetic Medical's Selling General Administrative is increasing as compared to previous years. The Aesthetic Medical's current Enterprise Value Over EBITDA is estimated to increase to 16.37, while Tax Provision is forecasted to increase to (14.4 M).

	2021	2022	2023	2024 (projected)
Interest Expense	27.2M	21.6M	14.5M	18.6M
Depreciation And Amortization	99.1M	61.5M	65.9M	71.1M

Interest Expense Depreciation And Amortization

Aesthetic Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.03	0.13	0.85	0.89	0.64	-0.06	0.18	-0.07	0.28	-0.48	-0.16	0.61	0.96	-0.62	0.56	0.62	0.48	0.04	-0.04	0.31	0.43	0.22	0.76	0.2	0.83
Other Current Liab	0.03		0.46	0.0	-0.16	-0.23	-0.74	0.59	-0.45	0.64	-0.57	-0.5	-0.27	0.08	-0.36	0.62	0.29	-0.07	-0.09	0.23	-0.04	0.38	-0.52	0.3	0.77	0.46
Total Current Liabilities	0.13	0.46		-0.21	-0.09	-0.21	-0.92	0.9	-0.86	0.75	-0.75	-0.87	-0.31	0.18	-0.81	0.79	0.65	-0.22	-0.27	0.7	-0.17	0.9	-0.89	-0.1	0.76	0.61
Total Stockholder Equity	0.85	0.0	-0.21		0.73	0.52	0.17	-0.15	0.27	0.13	-0.39	0.17	0.69	0.73	-0.23	0.28	0.24	0.58	0.34	-0.54	0.32	0.12	0.55	0.8	0.05	0.55
Other Liab	0.89	-0.16	-0.09	0.73		0.74	0.19	0.02	0.03	0.07	-0.17	-0.02	0.55	0.91	-0.42	0.29	0.42	0.35	-0.12	-0.02	0.14	0.17	0.32	0.7	-0.04	0.63
Net Tangible Assets	0.64	-0.23	-0.21	0.52	0.74		0.38	-0.19	0.41	-0.07	0.01	0.38	0.05	0.56	-0.27	0.26	0.05	0.78	-0.54	0.0	-0.22	-0.07	0.33	0.7	-0.14	0.42
Retained Earnings	-0.06	-0.74	-0.92	0.17	0.19	0.38		-0.91	0.87	-0.81	0.79	0.89	0.28	-0.12	0.7	-0.78	-0.61	0.3	0.11	-0.56	0.08	-0.83	0.87	0.03	-0.86	-0.58
Accounts Payable	0.18	0.59	0.9	-0.15	0.02	-0.19	-0.91		-0.91	0.9	-0.71	-0.92	-0.26	0.24	-0.72	0.76	0.62	-0.31	-0.24	0.62	-0.11	0.85	-0.89	0.1	0.87	0.63
Cash	-0.07	-0.45	-0.86	0.27	0.03	0.41	0.87	-0.91		-0.68	0.58	0.99	0.13	-0.21	0.65	-0.57	-0.69	0.61	0.08	-0.68	0.0	-0.81	0.85	0.19	-0.65	-0.48
Other Assets	0.28	0.64	0.75	0.13	0.07	-0.07	-0.81	0.9	-0.68		-0.81	-0.71	-0.2	0.24	-0.6	0.77	0.41	-0.02	-0.14	0.26	-0.12	0.75	-0.69	0.39	0.96	0.65
Long Term Debt	-0.48	-0.57	-0.75	-0.39	-0.17	0.01	0.79	-0.71	0.58	-0.81		0.63	-0.01	-0.42	0.77	-0.86	-0.58	-0.16	-0.02	-0.15	0.1	-0.84	0.49	-0.38	-0.78	-0.78
Cash And Short Term Investments	-0.16	-0.5	-0.87	0.17	-0.02	0.38	0.89	-0.92	0.99	-0.71	0.63		0.04	-0.29	0.7	-0.64	-0.76	0.54	0.02	-0.64	-0.11	-0.86	0.81	0.11	-0.69	-0.57
Net Receivables	0.61	-0.27	-0.31	0.69	0.55	0.05	0.28	-0.26	0.13	-0.2	-0.01	0.04		0.59	0.01	-0.13	0.34	0.01	0.73	-0.43	0.78	0.01	0.59	0.26	-0.26	0.22
Good Will	0.96	0.08	0.18	0.73	0.91	0.56	-0.12	0.24	-0.21	0.24	-0.42	-0.29	0.59		-0.66	0.55	0.72	0.27	-0.01	0.13	0.3	0.45	0.13	0.66	0.16	0.83
Common Stock Shares Outstanding	-0.62	-0.36	-0.81	-0.23	-0.42	-0.27	0.7	-0.72	0.65	-0.6	0.77	0.7	0.01	-0.66		-0.92	-0.86	-0.13	0.33	-0.62	0.07	-0.89	0.56	-0.3	-0.56	-0.9
Short Term Investments	0.56	0.62	0.79	0.28	0.29	0.26	-0.78	0.76	-0.57	0.77	-0.86	-0.64	-0.13	0.55	-0.92		0.71	0.27	-0.33	0.48	-0.1	0.83	-0.59	0.47	0.78	0.91
Inventory	0.62	0.29	0.65	0.24	0.42	0.05	-0.61	0.62	-0.69	0.41	-0.58	-0.76	0.34	0.72	-0.86	0.71		-0.14	0.03	0.57	0.39	0.83	-0.4	0.16	0.37	0.79
Other Current Assets	0.48	-0.07	-0.22	0.58	0.35	0.78	0.3	-0.31	0.61	-0.02	-0.16	0.54	0.01	0.27	-0.13	0.27	-0.14		-0.25	-0.33	-0.14	-0.1	0.41	0.66	-0.03	0.3
Other Stockholder Equity	0.04	-0.09	-0.27	0.34	-0.12	-0.54	0.11	-0.24	0.08	-0.14	-0.02	0.02	0.73	-0.01	0.33	-0.33	0.03	-0.25		-0.62	0.72	-0.06	0.43	-0.12	-0.15	-0.2
Total Liab	-0.04	0.23	0.7	-0.54	-0.02	0.0	-0.56	0.62	-0.68	0.26	-0.15	-0.64	-0.43	0.13	-0.62	0.48	0.57	-0.33	-0.62		-0.2	0.52	-0.77	-0.29	0.3	0.35
Long Term Investments	0.31	-0.04	-0.17	0.32	0.14	-0.22	0.08	-0.11	0.0	-0.12	0.1	-0.11	0.78	0.3	0.07	-0.1	0.39	-0.14	0.72	-0.2		0.07	0.33	0.05	-0.12	0.09
Short Long Term Debt	0.43	0.38	0.9	0.12	0.17	-0.07	-0.83	0.85	-0.81	0.75	-0.84	-0.86	0.01	0.45	-0.89	0.83	0.83	-0.1	-0.06	0.52	0.07		-0.68	0.13	0.68	0.76
Total Current Assets	0.22	-0.52	-0.89	0.55	0.32	0.33	0.87	-0.89	0.85	-0.69	0.49	0.81	0.59	0.13	0.56	-0.59	-0.4	0.41	0.43	-0.77	0.33	-0.68		0.26	-0.72	-0.33
Intangible Assets	0.76	0.3	-0.1	0.8	0.7	0.7	0.03	0.1	0.19	0.39	-0.38	0.11	0.26	0.66	-0.3	0.47	0.16	0.66	-0.12	-0.29	0.05	0.13	0.26		0.33	0.64
Common Stock	0.2	0.77	0.76	0.05	-0.04	-0.14	-0.86	0.87	-0.65	0.96	-0.78	-0.69	-0.26	0.16	-0.56	0.78	0.37	-0.03	-0.15	0.3	-0.12	0.68	-0.72	0.33		0.62
Property Plant Equipment	0.83	0.46	0.61	0.55	0.63	0.42	-0.58	0.63	-0.48	0.65	-0.78	-0.57	0.22	0.83	-0.9	0.91	0.79	0.3	-0.2	0.35	0.09	0.76	-0.33	0.64	0.62

Click cells to compare fundamentals

Aesthetic Medical Account Relationship Matchups

Aesthetic Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.0B	1.0B	576.9M	546.4M	560.7M	554.2M
Short Long Term Debt Total	342.3M	460.8M	405.9M	393.1M	209.1M	338.9M
Other Current Liab	79.0M	87.7M	89.4M	62.7M	275.5M	289.3M
Total Current Liabilities	265.3M	301.7M	541.7M	543.8M	411.4M	346.5M
Total Stockholder Equity	547.5M	390.9M	(156.7M)	(113.7M)	48.9M	46.4M
Other Liab	2.3M	12.7M	21.6M	285K	327.8K	311.4K
Net Tangible Assets	372.1M	182.5M	(193.9M)	(150.9M)	(135.8M)	(129.0M)
Retained Earnings	(242.2M)	(477.9M)	(1.1B)	(1.1B)	(1.2B)	(1.1B)
Accounts Payable	17.0M	33.7M	31.3M	46.8M	42.4M	29.5M
Cash	154.5M	44.4M	39.3M	12.2M	62.3M	64.9M
Non Current Assets Total	782.4M	831.9M	463.2M	468.8M	449.1M	514.2M
Non Currrent Assets Other	57.7M	51.9M	16.6M	48.4M	108.0M	113.4M
Other Assets	77.4M	83.2M	62.3M	109.5M	126.0M	77.3M
Long Term Debt	12.9M	110.1M	115.7M	29.1M	31.4M	29.8M
Cash And Short Term Investments	154.5M	44.4M	39.3M	12.2M	62.3M	66.9M
Net Receivables	84.1M	119.7M	43.9M	10.5M	9.8M	9.3M
Good Will	115.2M	161.5M	54.4M	33.0M	29.7M	53.2M
Common Stock Shares Outstanding	23.6M	21.7M	22.0M	27.3M	44.6M	31.1M
Short Term Investments	1.02	1.24	62.4M	42.2M	48.5M	50.9M
Liabilities And Stockholders Equity	1.0B	1.0B	576.9M	546.4M	560.7M	690.8M
Non Current Liabilities Total	191.2M	310.7M	221.7M	128.4M	115.7M	152.7M
Capital Lease Obligations	201.9M	214.9M	134.0M	126.7M	119.7M	109.6M
Inventory	26.1M	33.3M	30.6M	27.9M	15.6M	26.6M
Other Stockholder Equity	260.5M	901.2M	(41K)	(2.0M)	(1.8M)	(1.7M)
Total Liab	456.5M	612.4M	763.4M	672.3M	527.0M	602.8M
Long Term Investments	26.2M	10.3M	8.3M	4.9M	1.2M	0.0
Property Plant And Equipment Gross	534.7M	531.9M	735.7M	698.3M	720.0M	510.6M
Short Long Term Debt	127.5M	135.8M	156.2M	237.3M	93.4M	116.8M
Total Current Assets	264.7M	206.2M	113.7M	77.6M	111.6M	151.6M
Accumulated Other Comprehensive Income	789.3M	870.4M	909.4M	1.0B	1.2B	776.8M
Short Term Debt	163.7M	171.7M	184.5M	264.7M	93.4M	134.4M
Intangible Assets	60.2M	46.9M	(17.2M)	4.3M	36.9M	23.2M
Property Plant Equipment	519.3M	531.9M	358.7M	320.8M	368.9M	370.1M
Property Plant And Equipment Net	519.3M	531.9M	358.7M	320.8M	304.2M	389.8M
Current Deferred Revenue	5.5M	8.6M	236.5M	169.7M	195.2M	204.9M
Net Debt	187.8M	416.4M	366.6M	380.9M	146.7M	139.4M
Net Invested Capital	687.9M	636.8M	115.2M	152.8M	173.7M	315.1M

Pair Trading with Aesthetic Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aesthetic Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aesthetic Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Aesthetic Stock

0.52	OMI	Owens Minor Earnings Call This Week	Pair Corr
0.49	OGN	Organon	Pair Corr
0.43	DYAI	Dyadic International Financial Report 8th of May 2024	Pair Corr

The ability to find closely correlated positions to Aesthetic Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aesthetic Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aesthetic Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aesthetic Medical Intl to buy it.

The correlation of Aesthetic Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aesthetic Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aesthetic Medical Intl moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aesthetic Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Aesthetic Medical Intl offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aesthetic Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aesthetic Medical Intl Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aesthetic Medical Intl Stock:

How To Invest In Aesthetic

Details

Is Aesthetic Stock a good investment?

Details

What is Aesthetic Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aesthetic Medical Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Aesthetic Stock analysis

When running Aesthetic Medical's price analysis, check to measure Aesthetic Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aesthetic Medical is operating at the current time. Most of Aesthetic Medical's value examination focuses on studying past and present price action to predict the probability of Aesthetic Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aesthetic Medical's price. Additionally, you may evaluate how the addition of Aesthetic Medical to your portfolios can decrease your overall portfolio volatility.

	Global Correlations Find global opportunities by holding instruments from different markets
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Commodity Directory Find actively traded commodities issued by global exchanges
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume

Is Aesthetic Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aesthetic Medical. If investors know Aesthetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aesthetic Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

12.19

Earnings Share

(0.12)

Revenue Per Share

15.318

Quarterly Revenue Growth

0.105

Return On Assets

(0.06)

The market value of Aesthetic Medical Intl is measured differently than its book value, which is the value of Aesthetic that is recorded on the company's balance sheet. Investors also form their own opinion of Aesthetic Medical's value that differs from its market value or its book value, called intrinsic value, which is Aesthetic Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aesthetic Medical's market value can be influenced by many factors that don't directly affect Aesthetic Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aesthetic Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aesthetic Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aesthetic Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aesthetic Operating Income vs Net Income From Continuing Ops Analysis

Operating Income vs Net Income From Continuing Ops

Operating Income vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Operating Income

Net Income From Continuing Ops

Aesthetic Medical fundamental ratios Correlations

Aesthetic Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aesthetic Medical fundamental ratios Accounts

Pair Trading with Aesthetic Medical

Moving against Aesthetic Stock

Complementary Tools for Aesthetic Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 0.99	Cash
Good Will	+ 0.96	Total Assets
Common Stock	+ 0.96	Other Assets
Good Will	+ 0.91	Other Liab
Property Plant Equipment	+ 0.91	Short Term Investments
Accounts Payable	+ 0.9	Total Current Liabilities

Short Term Investments	- 0.92	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.92	Accounts Payable
Retained Earnings	- 0.92	Total Current Liabilities
Cash	- 0.91	Accounts Payable
Accounts Payable	- 0.91	Retained Earnings
Property Plant Equipment	- 0.9	Common Stock Shares Outstanding